Gynecology, Cervical cancer, Cervical intraepithelial neoplasia, Internal medicine and Meta-analysis are his primary areas of study. His Gynecology study combines topics in areas such as Colposcopy, Cervical screening, Mass screening, Cytology and Obstetrics. His Cervical cancer research is classified as research in Cancer.
His biological study spans a wide range of topics, including Cytopathology, Pregnancy, Relative risk and MEDLINE. In Internal medicine, he works on issues like Oncology, which are connected to Pathology, Randomized controlled trial and Immunohistochemistry. His studies in Meta-analysis integrate themes in fields like Cell, Human papillomavirus, Intensive care and Confidence interval.
His scientific interests lie mostly in Gynecology, Cervical cancer, Cervical intraepithelial neoplasia, Internal medicine and Obstetrics. The study incorporates disciplines such as Colposcopy, Papillomaviridae, Mass screening, Cytology and Cervical cancer screening in addition to Gynecology. His Cervical cancer research is multidisciplinary, incorporating elements of Family medicine and Vaccination.
His research investigates the connection with Cervical intraepithelial neoplasia and areas like Meta-analysis which intersect with concerns in Confidence interval. Marc Arbyn works mostly in the field of Internal medicine, limiting it down to concerns involving Oncology and, occasionally, Concordance. His Obstetrics research includes themes of Disease, Retrospective cohort study and Referral.
The scientist’s investigation covers issues in Cervical cancer, Internal medicine, Oncology, Genotyping and Family medicine. Cervical cancer is a subfield of Cancer that Marc Arbyn studies. His research in Oncology focuses on subjects like Cervical cancer screening, which are connected to MEDLINE and Vaccination.
Marc Arbyn has included themes like Concordance and Cytology in his Genotyping study. The concepts of his Family medicine study are interwoven with issues in Psychological intervention, Professional association and Cervix. His work in Colposcopy tackles topics such as Obstetrics which are related to areas like Hpv persistence and HPV Positive.
Marc Arbyn mostly deals with Cervical cancer, Cancer, Internal medicine, Family medicine and Cervical intraepithelial neoplasia. Marc Arbyn works in the field of Cervical cancer, namely Cervical cancer screening. HPV infection is the focus of his Cancer research.
His Meta-analysis and Squamous intraepithelial lesion investigations are all subjects of Internal medicine research. His study in Family medicine is interdisciplinary in nature, drawing from both Cervical screening and Colposcopy. His Cervical intraepithelial neoplasia study incorporates themes from Anus, Incidence, Carcinoma in situ, Relative risk and Neoplastic transformation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis
M Kyrgiou;G Koliopoulos;P Martin-Hirsch;M Arbyn.
The Lancet (2006)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco;Joakim Dillner;K Miriam Elfström;Sara Tunesi.
The Lancet (2014)
Worldwide burden of cervical cancer in 2008
M. Arbyn;M. Arbyn;X. Castellsagué;S. de Sanjosé;L. Bruni.
Annals of Oncology (2011)
Metaprop: a Stata command to perform meta-analysis of binomial data
Victoria N Nyaga;Marc Arbyn;Marc Aerts.
Archives of public health (2014)
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document
M. Arbyn;A. Anttila;J. Jordan;G. Ronco.
Annals of Oncology (2010)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick;Marc Arbyn;Rengaswamy Sankaranarayanan;Vivien Tsu.
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.
M Arbyn;M Kyrgiou;C Simoens;A O Raifu.
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Marc Arbyn;Guglielmo Ronco;Ahti Anttila;Chris J.L.M. Meijer.
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses
Marc Arbyn;Peter Sasieni;Chris J.L.M. Meijer;Christine Clavel.
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J.L.M. Meijer;Johannes Berkhof;Philip E. Castle;Albertus T. Hesselink.
International Journal of Cancer (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: